Clearmind Medicine Inc. (CMND) Operating cash flow 2021–2025
Clearmind Medicine Inc. (CMND) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.7MFY2025 · since FY2021: -$2.1M → -$4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.7M | +2.6% |
| FY2024 | -$4.9M | +22.9% |
| FY2023 | -$6.3M | -69.2% |
| FY2022 | -$3.7M | -79.3% |
| FY2021 | -$2.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CMND financial trends
CMND RevenueCMND Net incomeCMND Net marginCMND Gross profitCMND Gross marginCMND Operating incomeCMND Operating marginCMND Free cash flowCMND Capital expendituresCMND Return on equityCMND Stock buybacksCMND Dividends paidCMND Total assetsCMND Total liabilitiesCMND Shareholders’ equityCMND overview →